The Delhi government Saturday issued notices to two private laboratories for overcharging suspected swine flu patients for their screening tests, an official said.
The notices have been served to south Delhi-based Healthcare Diagnostics and west Delhi-based Global Diagnostics, after a surprise check was conducted by a health ministry team on the directions of Delhi health minister Satyendra Jain Friday night.
On Feb 18, the Directorate of Health Services (DHS) had directed all the 10 laboratories designated for conducting swine flu tests not to charge more than Rs.4,500.
In the notices, the labs have been asked why their licences should not be cancelled for cheating people in distress by failing to comply with the specified norms.
Delhi till Friday recorded 2,060 positive cases of swine flu with nine deaths.
It has also been found that these two laboratories have not been accredited by the state government for conducting the H1N1 tests.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app